| Business Type | Exporter, Supplier, Retailer |
| Use | Proteasome Inhibitor For Multiple Myeloma Treatment |
| Packaging Size | 3 X 1 Tablets |
| Packaging Type | Box |
| Click to view more | |
Product Details
COMPOSITION:
Each LuciXaz capsule contains: 5.7mg lxazomib citrate equivalent to lxazomib….………4mg
INDICATION:
LuciXaz is a proteasome inhibitor indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.
DOSAGE AND USE:
Recommended starting dose of 4 mg taken orally on Days 1, 8, and 15 of a 28-day cycle. Dose should be taken at least one hour before or at least two hours after food.
Capsule should be swallowed whole & not chewed or crushed.COMPOSITION:
Each LuciXaz capsule contains: 5.7mg lxazomib citrate equivalent to lxazomib….………4mg
INDICATION:
LuciXaz is a proteasome inhibitor indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.
DOSAGE AND USE:
Recommended starting dose of 4 mg taken orally on Days 1, 8, and 15 of a 28-day cycle. Dose should be taken at least one hour before or at least two hours after food.
Capsule should be swallowed whole & not chewed or crushed.COMPOSITION:
Each LuciXaz capsule contains: 5.7mg lxazomib citrate equivalent to lxazomib….………4mg
INDICATION:
LuciXaz is a proteasome inhibitor indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.
DOSAGE AND USE:
Recommended starting dose of 4 mg taken orally on Days 1, 8, and 15 of a 28-day cycle. Dose should be taken at least one hour before or at least two hours after food.
Capsule should be swallowed whole & not chewed or crushed.
* Currently we are not Accepting Orders for this Product.
